https://clinicaltrials.gov/ct2/show/NCT02906020?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F08%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of GZ/SAR402671 in Parkinson’s Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation
DESCRIPTION:
Condition: Parkinson’s Disease
Interventions: Drug: GZ/SAR402671; Drug: Placebo
Sponsor: Genzyme, a Sanofi Company
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT02906020
FIRST POSTED:
Mon, 19 Sep 2016 12:00:00 EDT
LAST UPDATE POSTED:
05/22/19 07:42AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT02906020?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F08%2F2019&lupd_d=14&sort=nwst
